Krystal Biotech Stock

Detail	Data
Volume (24h):	691,418 shares
P/E Ratio:	31.76
Forward P/E:	22.64
EPS:	4.17 USD
Forward EPS:	5.85 USD
Number of Shares:	28,898,700 shares
Market Capitalization:	3,827,921,920.00 USD

The interactive chart displays the price movement of Krystal Biotech shares and updates every 15 minutes. It shows both the current price and historical trends. The chart offers various time frames, including daily, weekly, or monthly views, as well as the entire trading history.

Disclaimer: The data provided is for informational purposes only. Despite our efforts to ensure accuracy, it may contain errors or be outdated. We strongly recommend verifying the data from other independent sources. No investment decisions should be made based on this information.

Dividend

Dividend	Value
Dividend Amount	According to our data, the company Krystal Biotech does not currently pay dividends.
Annual Yield %:	-
Ex-dividend Date:	-
5-Year Avg Yield %:	-
Payout Ratio:	-
Last Dividend Value:	-
Last Dividend Date:	-

Analyst Forecast

Most analysts have issued a none recommendation for Krystal Biotech stock. The current number of analysts covering this company is 10. The highest target price is 245 USD, while the lowest target price is 155 USD. The median target valuation set by analysts is 201 USD. These forecasts and recommendations provide insight into how analysts view the future stock performance of Krystal Biotech.

Analysts	Recommendation
Issued Recommendation:	According to our data, the recommendation for Krystal Biotech stock is: none
Number of Analysts:	10
Highest Target Price:	245 USD
Lowest Target Price:	155 USD
Median Target Price:	201 USD

Fundamental Indicators

Indicator	Data
Total Revenue:	333,448,000.00 USD
Net Income:	123,960,000.00 USD
Price-to-Book (P/B):	3.89
PEG Ratio:	/
Exchange:	NasdaqGS
Industry:	Biotechnology
Sector:	Healthcare
Number of Employees:	275
Country:	United States

Where to Buy Krystal Biotech Stock?

You can purchase Krystal Biotech stock on the NasdaqGS under the ticker symbol: KRYS. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

*To verify the availability of specific stocks on the platform, it's a good idea to first open a free demo account. Not all stocks are available.

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5

Invest in Stocks with eToro

★★★★★ 5.0

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5

Try Free Demo Account

★★★★☆ 4.8

Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Krystal Biotech Stock

Indicator	Value
Company Revenue:	333,448,000.00 USD
EBITDA:	135,908,000.00 USD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share:	4.17 USD
Book Value Per Share:	34.07 USD
Total Cash:	616,846,016.00 USD
Total Cash per Share:	21.35 USD
Total Debt:	9,662,000.00 USD
Debt to Equity Ratio:	0.01
Quick Ratio	9.06
Current Ratio	9.65
Free Cash Flow	76,742,496.00 USD
Operating Cash Flow	138,500,992.00 USD
Gross Margins	93.20 %
EBITDA Margins	40.76 %
Operating Margins	41.03 %
Profit Margins	37.18 %
Return on Assets	8.7 %
Return on Equity	13.9 %
Earnings Growth (1 year)	3,900.0%
Revenue Growth (1 year)	94.9 %
Quarterly Earnings Year-over-Year Growth	3,734.0 %
Market Capitalization	3,827,921,920.00 USD
Enterprise Value	3,220,735,232.00 USD
EV/Revenue	9.659
EV/EBITDA	23.698
Float Shares	22,814,352 shares
Shares Outstanding	28,898,700 shares
Held Percent Insiders	0.12 %
Held Percent Institutions	104.11 %
Shares Short	2,921,085
Shares Short Prior Month	2,367,240
Date Short Interest	2025-05-30
Short Percentage of Total Shares	10.11 %
Short Ratio	6.99
Beta	0.66
Short Percentage of Float	16.96 %
Implied Shares Outstanding	28,898,700

Frequently Asked Questions (FAQ)

1️⃣ Does Krystal Biotech pay dividends?

According to our data, the company Krystal Biotech does not pay dividends yet, even in 2025.

2️⃣ Where to buy Krystal Biotech shares?

Krystal Biotech shares are traded on the NasdaqGS stock exchange under the ticker: KRYS. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

3️⃣ What is the forecast for Krystal Biotech shares?

According to our data, the recommendation for Krystal Biotech shares is from a total of 10 analysts. The average target price prediction is 201 USD per share.

4️⃣ What is the total number of shares and the value of Krystal Biotech on the stock exchange?

The total number of Krystal Biotech shares on the exchange is 28,898,700.00 shares, which at the current market capitalization gives the company a total valuation of 3,827,921,920.00 USD.